Spero Therapeutics' IPO

Spero Therapeutics raised a round of funding on November 02, 2017. Investors include Public.

Spero Therapeutics is a global multi-asset clinical-stage biopharmaceutical company dedicated to developing a novel and highly differentiated pipeline of antibacterials focused on unmet needs of patie…

Articles about Spero Therapeutics' IPO: